3 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
OPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) (OPTiMiSE)
Date du début: 1 févr. 2010, Date de fin: 31 juil. 2016,
OPTiMiSE (OPtimization of Treatment and Management of Schizophrenia in Europe) will focus on two goals: optimising current treatments in Schizophrenia and explore novel therapeutic options for schizophrenia. The project intends to both address basic, but so far unanswered, questions in the treatment of schizophrenia and develop new and experimental interventions. It is expected that the project wi ...
Voir le projet
25
Participants partenaires
TERMINÉ
Psychiatric Diagnostic and Prevention Consortium (PSYCHDPC)
Date du début: 1 janv. 2012, Date de fin: 31 juil. 2016,
PsychDPC contains leading European centres in genetics and psychiatry, richly endowed with expertise in both clinical and basic research. The partners bring together state-of-the-art technical facilities, high academic standards as well as established training activities, which will be utilized in concert to maximise the outcome of the project. The primary aim of PsychDPC is to translate data emer ...
Voir le projet
6
Participants partenaires
TERMINÉ
Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia (CRESTAR)
Date du début: 1 nov. 2011, Date de fin: 31 oct. 2015,
Treatment resistant schizophrenia (TRS) is the most disabling of all psychiatric illnesses, affecting about 1/3 of patients (~1 million Europeans), a considerable economic and social burden. First-line treatments include atypical (e.g. olanzapine) and typical (e.g. haloperidol) antipsychotics. The original atypical, clozapine, is a final option, and although it is the only antipsychotic shown to b ...
Voir le projet